Picture of WuXi Biologics (Cayman) logo

2269 — WuXi Biologics (Cayman) News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeLarge CapHigh Flyer

Brief: Wuxi Biologics Noted Meeting On, Among Others, Revised Version Of Draft Bill

May 17 (Reuters) - WuXi Biologics (Cayman) Inc
 2269.HK :
    * NOTED MEETING ON, AMONG OTHERS, REVISED VERSION OF DRAFT
BILL
WAS HELD BY U.S. HOUSE COMMITTEE ON OVERSIGHT AND ACCOUNTABILITY
    * CONTENTS OF REVISED DRAFT BILL REMAIN SUBJECT TO FURTHER
REVIEW
AND MODIFICATION AS IT MOVES THROUGH LEGISLATIVE PROCESS
    * CO DOES NOT HAVE HUMAN GENOMICS BUSINESS, NOR DOES IT
COLLECT
HUMAN GENOMIC DATA IN ANY OF ITS BUSINESSES


Further company coverage:  2269.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on WuXi Biologics (Cayman)

See all news